BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2526292)

  • 1. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
    Raymond JR; Fargin A; Lohse MJ; Regan JW; Senogles SE; Lefkowitz RJ; Caron MG
    Mol Pharmacol; 1989 Jul; 36(1):15-21. PubMed ID: 2526292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C; Fuchs S
    Mol Pharmacol; 1991 Nov; 40(5):712-6. PubMed ID: 1834930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    Jarvie KR; Niznik HB; Seeman P
    Mol Pharmacol; 1988 Aug; 34(2):91-7. PubMed ID: 2970586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
    Amlaiky N; Caron MG
    J Biol Chem; 1985 Feb; 260(4):1983-6. PubMed ID: 2579064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H; Emerit MB; el Mestikawy S; Cossery JM; Marquet A; Besselievre R; Hamon M
    J Recept Res; 1987; 7(1-4):195-221. PubMed ID: 2957498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
    Boundy VA; Lu L; Molinoff PB
    J Pharmacol Exp Ther; 1996 Feb; 276(2):784-94. PubMed ID: 8632351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
    Vaughan RA
    Mol Pharmacol; 1995 May; 47(5):956-64. PubMed ID: 7746282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    Patel A; Craig RH; Daluge SM; Linden J
    Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
    Burris KD; Filtz TM; Chumpradit S; Kung MP; Foulon C; Hensler JG; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1994 Feb; 268(2):935-42. PubMed ID: 8114008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
    Clagett-Dame M; McKelvy JF
    Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol.
    Rong Y; Arbabian M; Thiriot DS; Seibold A; Clark RB; Ruoho AE
    Biochemistry; 1999 Aug; 38(35):11278-86. PubMed ID: 10471277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
    J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.